Skip to content

Bioventus BVS Accrued interest

Accrued interest at other companies

Artivion logo
ArtivionAORT
$4.48M-33.7%
Enovis logo
EnovisENOV
$9.64M+54.7%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$4.85M
SI-BONE, Inc. logo
SI-BONE, Inc.SIBN
$600K+50.0%

Other financials

Income statement

See full
Revenue$132.1M+6.6%
Gross profit$90.8M+9.3%
Operating income$8.4M+72.8%
Net income$3.1M+218%
EPS (diluted)$0.04+200%

Balance sheet

See full
Cash & equivalents$35.8M+57.2%
Total debt$288.4M-21.2%
Total equity$188.9M+27.5%
Total assets$650.5M-5.9%

Cash flow

See full
Operating cash flow$8.9M+146%
CapEx$574.0K-30.5%
Free cash flow$8.4M+141%

Valuation

See full
Market cap$659.19M+51.7%
Enterprise value$911.76M+17.2%
P/E23.1×
P/S1.1×+0.4×

Profitability

See full
Gross margin68.7%+1.2pp
Operating margin10%
Net margin4.9%+3.2pp
FCF margin17.5%+13.2pp

Returns & leverage

See full
Return on equity16.9%+10.9pp
Debt / equity1.5×-0.9×
Current ratio1.7×+0.3×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept us-gaap:InterestPayableCurrentAndNoncurrent.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's accrued interest.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bioventus's accrued interest?
Bioventus (BVS) reported accrued interest of $2.85M in Q1 2026.
How has Bioventus's accrued interest changed year-over-year?
Bioventus's accrued interest decreased by 37.8% year-over-year, from $4.58M to $2.85M.
What is the long-term trend for Bioventus's accrued interest?
Over 3 years (2022 to 2025), Bioventus's accrued interest has grown at a 144.4% compound annual growth rate (CAGR), from $217K to $3.17M.
What does accrued interest mean?
Interest expense accrued but not yet paid on outstanding debt obligations, based on contractual interest rates and time elapsed.